Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib

Indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO2) are the key enzymes of tryptophan (TRP) metabolism in the kynurenine pathway (KP). Both enzymes function as indicators of immunosuppression and poor survival in cancer patients. Direct or indirect targeting of either of these su...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Christin Riess, Björn Schneider, Hanna Kehnscherper, Julia Gesche, Nina Irmscher, Fatemeh Shokraie, Carl Friedrich Classen, Elisa Wirthgen, Grazyna Domanska, Annette Zimpfer, Daniel Strüder, Christian Junghanss, Claudia Maletzki
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2020-02-01
Collection:Frontiers in Immunology
Sujets:
targeted therapy
solid tumor models
tryptophan metabolites
IDO1
chemotherapy
Accès en ligne:https://www.frontiersin.org/article/10.3389/fimmu.2020.00055/full
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires